Home › Regeneron Pharms Receives Neutral Rating from Zacks
 

Keywords :   


Regeneron Pharms Receives Neutral Rating from Zacks

2013-02-19 04:07:39| Biotech - Topix.net

's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday.

Tags: rating receives neutral zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »